Neo Ivy Capital Management Invitae Corp Transaction History

Neo Ivy Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$14.7 - $28.67 $46,084 - $89,880	-3,135 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$24.31 - $33.6 $42,323 - $58,497	1,741 Added 124.89%	3,135 $95,000
Q2 2021 Aug 16, 2021	BUY	$26.09 - $40.4 $36,369 - $56,317	1,394 New	1,394 $47,000
Q4 2020 Feb 16, 2021	SELL	$39.09 - $57.4 $39,168 - $57,514	-1,002 Closed	0 $0
Q3 2020 Nov 17, 2020	BUY	$28.43 - $44.67 $28,486 - $44,759	1,002 New	1,002 $43,000

Q2 2020 Aug 17, 2020	SELL	$11.71 - $30.29 $36,710 - $94,959	-3,135 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$11.71 - $30.29 $36,710 - $94,959	3,135 New	3,135 $95,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

Stay updated on Neo Ivy Capital Management with notifications on news.